Which governmental body regulates Medication-Assisted Treatment (MAT) in the United States?

The Substance Abuse and Mental Health Services Administration (SAMHSA) is the governmental body responsible for regulating Medication-Assisted Treatment (MAT) in the United States. SAMHSA plays a crucial role in overseeing the treatment and prevention of substance use and mental disorders, providing guidance on best practices for MAT, and ensuring access to effective treatment options. This includes the regulation of medications used in MAT, such as buprenorphine and methadone, as well as the associated treatment programs that incorporate these medications to support individuals with substance use disorders.

In addition to its regulatory role, SAMHSA also facilitates training, funding, and resource development to improve the quality of MAT services nationwide. It aims to enhance the public's awareness of the effectiveness of MAT as part of a comprehensive treatment approach for individuals struggling with opioid dependence and other substance use disorders. This overarching role distinguishes SAMHSA from other organizations, which may focus on more specific aspects of health or substance use without directly regulating treatment protocols.